Performance Optimization

A baseline is not a single number. It is a distribution. To say “this athlete’s resting HRV is 70 ms” is uninformative; to say “this athlete’s resting HRV averages 70 ms with a standard deviation of 6 ms over the past four weeks” is the start of a useful reference.

The protocol that delivers usable baselines:

• Collect data for at least 4-6 weeks before drawing inferences.
• Standardise measurement conditions (HRV: first thing in the morning, supine, controlled breathing, before caffeine; sleep: same wearable each night).
• Compute the individual mean and standard deviation for each metric.
• Define personalised reference ranges, typically ±1 SD from the individual mean for “within normal range”, and ±2 SD for “anomaly worth investigating”.

Research evidence. Plews, Laursen, Stanley, Kilding, and Buchheit (2013) demonstrated that HRV interpretation must be rooted in the individual: population norms are misleading because between-athlete variability dwarfs within-athlete day-to-day variability for the athletes whose training adaptation matters most. The principle generalises across metrics: compared to themselves, not to the squad.

Practical tip. A useful structure is a one-page “individual athlete profile” (Template A3) that displays the mean, SD, and current value for each tracked metric, with a traffic-light indicator. This document is the coach’s morning-meeting reference.

Classic periodisation models (linear, block, undulating, conjugate) were designed before continuous monitoring. They are not replaced by wearables; they are augmented.

Microcycle (one week). Wearables enter the microcycle through daily readiness. Each morning, the coach reads HRV, sleep, and wellness; categorises the athlete as green, amber, or red; and adjusts the day’s session accordingly. The decision rules are pre-defined (see Template A8) so the call is not improvised under pressure.

Mesocycle (3-6 weeks). Wearables enter the mesocycle through progressive overload management. The coach plans week-by-week increases in load (typically 5-10% per week within a block). Weekly load reports compare planned versus actual external load and observed internal-load response, allowing the coach to see whether the planned progression is being tolerated.

Macrocycle (one season). Wearables enter the macrocycle through long-arc adaptation tracking: for example, declining resting HR at the same training load suggests cardiorespiratory adaptation; stable CMJ height across a heavy block suggests neuromuscular preservation under load.

The principle: data does not write the plan. Data tells you whether the plan you wrote is doing what you intended.

Three recovery domains, none sufficient on its own.

Heart rate variability (HRV). HRV reflects autonomic nervous system status: broadly, the balance between sympathetic (mobilisation) and parasympathetic (recovery) input to the heart. Higher resting HRV, in general and over time, indicates parasympathetic dominance consistent with recovered status. Lower HRV, particularly a sustained downward trend, indicates accumulated stress. Caveats: HRV is sensitive to alcohol, illness, life stress, and the measurement protocol; a single day’s reading should never trigger action: the trend over 5-7 days is what matters.

Sleep. Total sleep time, sleep efficiency (time asleep divided by time in bed), and time in each sleep stage are reported by most consumer wearables. Total sleep time and sleep efficiency are reasonably reliable in research validation against polysomnography (PSG); stage classification (deep, REM, light) is less accurate from consumer devices, and coaches should be cautious about acting on stage-level data. The actionable rule: track total sleep time and efficiency; treat stage data as suggestive, not definitive.

Research evidence. Walsh, Halson, Sargent, Roach, and colleagues’ 2021 expert consensus on sleep and the athlete provides the most current and authoritative practitioner reference. Coaches should be familiar with its core recommendations: pursue 7-9 hours nightly as a baseline; protect sleep on competition eve; treat persistent sleep disturbance as a wellbeing issue requiring intervention.

Subjective wellness. A simple morning questionnaire (five items rated 1-5: sleep quality, fatigue, soreness, mood, stress) costs nothing and adds the athlete’s own experience to the picture. Saw, Main, and Gastin (2016) showed that subjective measures often outperform objective ones for tracking acute training response. Coaches who rely only on devices and never ask the athlete are missing the most informative signal.

The discipline of triangulation: never act on one metric alone. HRV down, sleep fine, wellness fine = monitor, perhaps a single life-stress event. HRV down, sleep declining, wellness declining = intervene.

Tapering reduces accumulated fatigue while preserving fitness, allowing peak performance at a competition. Mujika and Padilla’s (2003) reviews remain the foundational reference; a later meta-analysis (Bosquet, Montpetit, Arvisais, & Mujika, 2007) supplies the figures: optimal taper typically reduces training volume by 41-60% over 8-14 days, while maintaining or even slightly increasing intensity, and reducing frequency only modestly.

Wearable data adds confirmation, not redesign. During a well-executed taper, expect:

• HRV to rise as parasympathetic recovery exceeds training-induced sympathetic load.
• Subjective wellness to improve (mood up, fatigue down, soreness down).
• CMJ height to rise modestly as neuromuscular freshness returns.
• Resting HR to drift down slightly.

If the data shows the opposite (HRV declining, wellness worsening) during the taper, the plan is not working. The coach should investigate: is residual fatigue greater than expected? Is the athlete sleeping poorly? Is life stress confounding the picture? The intervention is not “ignore the plan”; it is “diagnose and adjust”.

Worked example. A 14-day taper for an 800-metre runner: volume reduced from 60 km/week (baseline block) to 30 km/week at day −14, then 22 km/week at day −7, then 12 km/week in the final week. Intensity preserved: race-pace work continued at full effort, reduced in volume. Through the taper, the athlete’s HRV moved from 65 ms (baseline mean) to 71 ms by day −5; CMJ height rose from 38 cm to 40 cm; subjective wellness composite rose from 3.6/5 to 4.2/5. The data confirmed the taper was working. On race day, the athlete ran a personal best.

The most-ignored design question in monitoring is: what is the cost of measuring this?

• Athlete time (morning HRV measurement adds 5 minutes per day per athlete).
• Equipment cost and maintenance.
• Staff analysis time.
• Risk of number anxiety: athletes becoming preoccupied with their own metrics in unhelpful ways. This risk is non-trivial, particularly among adolescents and athletes prone to perfectionism.

Before adding any metric, ask honestly: what decision will this change? If the answer is “none”, the metric should not be in the system. A small set of well-used metrics outperforms a large set of unused ones.